Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) Income from Continuing Operations (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Income from Continuing Operations data on record, last reported at 414115000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 22.29% year-over-year to 414115000.0; the TTM value through Dec 2025 reached 1186551000.0, up 403.82%, while the annual FY2025 figure was 1243947000.0, 428.19% up from the prior year.
  • Income from Continuing Operations reached 414115000.0 in Q4 2025 per PTCT's latest filing, up from 23074000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 866562000.0 in Q1 2025 and bottomed at 198883000.0 in Q2 2023.
  • Average Income from Continuing Operations over 5 years is 13958800.0, with a median of 113842500.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: plummeted 139.93% in 2023, then soared 1046.28% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 137704000.0 in 2021, then soared by 383.35% to 390185000.0 in 2022, then tumbled by 139.93% to 155792000.0 in 2023, then surged by 442.07% to 532921000.0 in 2024, then fell by 22.29% to 414115000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 414115000.0 in Q4 2025, 23074000.0 in Q3 2025, and 71052000.0 in Q2 2025.